Prognostic factors for overall survival in elderly patients with advanced ovarian cancer treated with chemotherapy: Results of a pooled analysis of three GINECO phase II trials-Reference-Cited by-同舟云学术

Prognostic factors for overall survival in elderly patients with advanced ovarian cancer treated with chemotherapy: Results of a pooled analysis of three GINECO phase II trials

Published:2016-10 Issue:1 Volume:143 Page:22-26
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Tinquaut Fabien,Freyer Gilles,Chauvin Franck,Gane Nicolas,Pujade-Lauraine Eric,Falandry Claire^ORCID

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference24 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J. Clin.,2010

2. Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experience;Pectasides;Int. J. Gynecol. Cancer,2007

3. Survival and prognostic factors in patients with ovarian cancer;Tingulstad;Obstet. Gynecol.,2003

4. Ovarian cancer. Survival and treatment differences by age;Ries;Cancer,1993

5. Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population-based study;Sundararajan;J. Clin. Oncol.,2002

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial;Gynecologic Oncology;2024-08

2. Examining the impact of age on chemotherapy completion in epithelial ovarian, fallopian tube and primary peritoneal cancer: a retrospective cohort study in Thailand;BMJ Open;2024-07

3. Comparison of older and younger patients with ovarian cancer: A post hoc study (JGOG3016‐A3) of the treatment strength and prognostic outcomes of conventional or dose‐dense chemotherapy;Journal of Obstetrics and Gynaecology Research;2023-03

4. Ovarian cancer in the older patient: where are we now? What to do next?;Therapeutic Advances in Medical Oncology;2023-01

5. NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022;Journal of the National Comprehensive Cancer Network;2022-09